Capital Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$283K Buy
+4,198
New +$280K ﹤0.01% 661
2026
Q1
– Sell
-3,053
Closed -$203K – 760
2025
Q4
$203K Buy
+3,053
New +$197K ﹤0.01% 698
2025
Q3
– Sell
-2,839
Closed -$248K – 734
2025
Q2
$248K Buy
+2,839
New +$223K ﹤0.01% 615
2025
Q1
– Sell
-2,648
Closed -$206K – 685
2024
Q4
$206K Buy
+2,648
New +$196K ﹤0.01% 618

Other funds holding DXCM

Capital Investment Advisors's DXCM Position: Q2 2026 in Review

Capital Investment Advisors opened a new position in DexCom (DXCM) in Q2 2026: 4,198 shares worth $283K. The stake represents ﹤0.01% of the portfolio and ranks #661 among its holdings. This is a return to the name: Capital Investment Advisors previously reported a position in DXCM as recently as Q4 2025.

Capital Investment Advisors first reported a position in DXCM in Q4 2024 and has held it in 4 quarters since. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Capital Investment Advisors held 4,198 shares of DexCom worth $283K as of Q2 2026.
  • DexCom was a new Capital Investment Advisors position in Q2 2026.
  • DexCom made up ﹤0.01% of Capital Investment Advisors's portfolio in Q2 2026, its #661 holding.
  • Capital Investment Advisors first reported a position in DexCom in Q4 2024 and has held it in 4 quarters since.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Capital Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.